INTEGUMED, LLC

Medtech

Lipid ether amine (LEA) topical compounds targeting bacterial biofilm lipid metabolism and host phospholipase activity in chronic wounds

Grants
$300K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Phospholipid antimetabolite lipid ether amines for topical treatment of chronic wounds and associated biofilms.$299,749
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1691Radiologics, Inc.——
1692NATURAL NIPPLE CORP., THE——
1693Agenus Inc.—$221M
1694INTEGUMED, LLC——
1695ZBEATS, INC.——
1696MOLECULAR SURFACE TECHNOLOGIES LLC——
1697TEARDX, LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.